Basit öğe kaydını göster

dc.contributor.authorMESUT, Burcu
dc.contributor.authorOnal, Cem
dc.contributor.authorAksu, Buket
dc.contributor.authorERGİNER, Yıldız
dc.date.accessioned2021-12-10T10:08:36Z
dc.date.available2021-12-10T10:08:36Z
dc.date.issued2021
dc.identifier.citationMESUT B., Onal C., Aksu B., ERGİNER Y., "Examining the basic principles of quality by design (QbD) approach in analytical studies", ISTANBUL JOURNAL OF PHARMACY, cilt.51, sa.2, ss.271-276, 2021
dc.identifier.othervv_1032021
dc.identifier.otherav_2b8d2f4f-d3c2-4699-9ee1-47fca009ead5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169279
dc.identifier.urihttps://doi.org/10.26650/istanbuljpharm.2020.0087
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/2b8d2f4f-d3c2-4699-9ee1-47fca009ead5/file
dc.description.abstractAlthough the first application of Quality by Design (QbD) concept started for product development studies, the number of studies regarding its application to analytical development has been increased recently. Basically, QbD strategy in both formulation development and analytic studies are identical logically and conceptually, but they have some differences in terms of its terminology and application. Essential terminology and approach differences in this concept are; the determination of the analytic target profile, critical method characteristics, critical process parameters, and the determination of the method study area. However, the risk evaluation method which is necessary for the appropriate application of quality by design is also an inseparable part of the analytical quality by design. Despite those terminological differences, developing a quality-based method with the analytical design that contributes to research with an appropriately applied risk-based design quality approach and provides multiple advantages that will be noticed each and every time, will be useful both for researchers and authorities who investigate license documentation and changes. Therefore, the terminology which is used for analytic quality by design and appropriate risk evaluation approaches are explained in this study.
dc.language.isoeng
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacology (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.titleExamining the basic principles of quality by design (QbD) approach in analytical studies
dc.typeMakale
dc.relation.journalISTANBUL JOURNAL OF PHARMACY
dc.contributor.departmentCinnaGen Pharmaceut , ,
dc.identifier.volume51
dc.identifier.issue2
dc.identifier.startpage271
dc.identifier.endpage276
dc.contributor.firstauthorID2721316


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster